Time dependence of estrogen receptor expression in human hearts
作 者 摘 要Transcriptional effects of estrogens are primarily mediated by the two nuclear estrogen receptors (ER), ERα and ERβ. Both receptors are present in the vasculature and in the human heart and have been shown to act antiatherogenic and to be protective against the development of cardiac hypertrophy. The aim was to quantify ER mRNA expression in left ventricular specimens from patients with coronary heart disease (CHD, n = 15) and dilated cardiomyopathy (CMP, n = 38) and compare their levels with those from healthy heart donors (n = 9). Additionally, a possible variation of ERmRNA expression in human hearts in respect to time of day was studied.
mRNA expression of both ER receptors was detected by real-time PCR in all of the human specimens. There was no difference in the relative quantity of the receptors between CHD and CMP patients. However, control specimens showed significant lower levels of either receptor in the healthy myocardium (p < .001 each). Analyzing the time dependency of receptor expression with a cosinor analysis showed a significant 8-hour period rhythm for ERβ in CMP- but no rhythm in CHD patients. Due to the low patient number, rhythmic analysis was not possible in controls.
The increased ERα and ERβ mRNA expression in left ventricular specimens from CHD and CMP patients might reflect a compensatory mechanism to counteract the decline in ventricular function. Furthermore, we provided evidence for a time dependent variation of ERβ receptor expression in the human heart.
详细资料 标 签
相关链接
DOI URL
dr.qinan 的文献笔记 订阅 |
Estrogen has already been shown very important to bone biology, where decreased estrogen is associated with increased bone loss. Here in this paper, they showed the different expression of estrogen receptor in heart disease, it will be of interesting to see the different function in different tissues. BTW, they may share the same signalling pathway in different tissues. |
Homozygous stop mutation in the SNX10 gene in a consanguineous Iraqi boy with osteopetrosis and corpus callosum hypoplasiaDenosumab may reduce hypercalcaemia after transplantation for osteopetrosis
浙公网安备 33010202000686号 ( 浙ICP备09035230号-1 )
